Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
PaperCitations, authors & open-access status
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 170 citations, 2024 year and hybrid oa status.
170
Citations
2024
Year
hybrid
OA Status